Key result
Focal CAD linked to ~77% lower 2-year residual angina vs diffuse disease after PCI.
Why the study?
Does the interaction between baseline angiography-derived lesion functional phenotype (focal vs diffuse) and post-PCI adequacy of flow (μFR >0.90) influence residual angina at 2 years in patients with chronic coronary syndrome undergoing PCI?
Cohort (n=186)
Open-label
Yes
Does the interaction between baseline angiography-derived lesion functional phenotype (focal vs diffuse) and post-PCI adequacy of flow (μFR >0.90) influence residual angina at 2 years in patients with chronic coronary syndrome undergoing PCI?
Answers are grounded in this paper and cite their sources.
The ability of baseline focal versus diffuse CAD phenotype to predict 2-year freedom from angina after PCI depends on achieving global post-PCI adequacy of flow (μFR >0.90).
BACKGROUND: Focal stenotic coronary lesions, as defined by the invasive pullback pressure gradient index (PPGI) measured before percutaneous coronary intervention (PCI), are associated with less residual angina than diffuse lesions as assessed by the Seattle Angina Questionnaire (SAQ). OBJECTIVES: This study aims to investigate the interaction between a lesion's baseline functional phenotype (focal vs diffuse) and the physiological success of PCI, as defined by a post-procedural Murray-based angiography-derived flow ratio (μFR) above 0.90 (adequacy of flow [AOF]), in correlation with angina status at 2 years. METHODS: The ASET-Japan study enrolled 203 patients with chronic coronary syndrome. The baseline functional disease pattern and the achievement of AOF (post-PCI μFR > 0.90) were analyzed as potential factors influencing the rate of residual angina at 2 years. RESULTS: SAQ scores were obtained in 186 patients. The median follow-up duration was 771 days (Q1-Q3: 752-805). AOF was achieved in in 61.3% (114 of 186; 95% CI: 54.1-68.0), with the μFR post-PCI differing significantly by the lesion's baseline phenotype (diffuse 0.92 ± 0.06 vs focal 0.94 ± 0.04; P < 0.001). At 2-year follow-up, patients in the AOF group with preprocedural focal vs diffuse disease had significantly better angina frequency scores (99.2 ± 3.3 vs 94.8 ± 11.7; P = 0.007), and less frequent residual angina (6.7%; 4 of 60; 95% CI: 2.6-16.2 vs 22.0%; 11 of 50; 95% CI: 12.5-34.9; P = 0.040). CONCLUSIONS: In patients who achieve AOF during PCI, the baseline functional phenotype of treated lesions in patients with or without angina at follow-up is significantly different. A global physiological assessment integrating AOF and the baseline functional pattern of disease is potentially useful to accurately predict residual angina post-PCI. (Acetyl Salicylic Elimination Trial Japan: The ASET Japan Pilot Study [ASET-JAPAN], NCT05117866).
No takes yet. Share an insight, caveat, or question.
Miyashita et al. (2026) conducted a cohort in Chronic coronary syndrome undergoing PCI (n=186). Focal coronary artery disease phenotype (pre-PCI PPGI ≥0.68) with post-PCI adequacy of flow (μFR >0.90) vs. Diffuse coronary artery disease phenotype (pre-PCI PPGI <0.68) with post-PCI adequacy of flow (μFR >0.90) was evaluated on Residual angina (SAQ Angina Frequency score <100) at 2 years among patients achieving post-PCI adequacy of flow (OR 0.234 (diffuse vs focal for freedom from angina), 95% CI 0.078-0.702, p=0.040). Preprocedural focal versus diffuse CAD in patients achieving post-PCI adequacy of flow resulted in less residual angina at 2 years.
Synapse has enriched 10 related papers. Consider them for comparative context: